Het Reinier de Graaf Gasthuis is een ziekenhuis in de Zuid-Hollandse gemeente Delft, gelegen in het westen grenzend aan Den Hoorn. Het ziekenhuis is genoemd naar de arts Reinier de Graaf en telt ongeveer 3000 medewerkers waarvan ongeveer 200 medisch specialisten.

During the past decade, Reinier de Graaf Gasthuis conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 9 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 3 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Reinier de Graaf Gasthuis" #1 sponsor was "Radboud University Medical Center" with 12 trials, followed by "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 11 trials sponsored, "The Netherlands Cancer Institute" with 10 trials sponsored, "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 8 trials sponsored and "Erasmus Medical Center" with 8 trials sponsored. Other sponsors include 72 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Reinier de Graaf Gasthuis" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 11 trials as a collaborator, "Borstkanker Onderzoek Groep" with 8 trials as a collaborator, "Dutch Cancer Society" with 7 trials as a collaborator, "Reinier de Graaf Groep" with 7 trials as a collaborator and "Catharina Ziekenhuis Eindhoven" with 5 trials as a collaborator. Other collaborators include 218 different institutions and companies that were collaborators in the rest 171 trials.

According to Clinical.Site data, the most researched conditions in "Reinier de Graaf Gasthuis" are "Breast Cancer" (10 trials), "Atrial Fibrillation" (3 trials), "Colorectal Cancer" (3 trials), "Deep Venous Thrombosis" (3 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "Reinier de Graaf Gasthuis" in a lesser frequency.

Most popular intervention types in "Reinier de Graaf Gasthuis" are "Drug" (67 trials), "Other" (23 trials), "Procedure" (19 trials), "Device" (11 trials) and "Biological" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Paclitaxel" (4 trials), "Carboplatin" (3 trials), "Ibrutinib" (3 trials) and "Obinutuzumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Reinier de Graaf Gasthuis" are 103 trials for "All" genders, 17 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Reinier de Graaf Gasthuis". undefined are not yet recruiting, 25 are recruiting, 28 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 47 completed trials in Reinier de Graaf Gasthuis, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Reinier de Graaf Gasthuis, 2 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 29 trials that are defined as “Not Applicable".